Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
H
|
Haldex AB
LSE:0O93
|
SE |
|
OKP Holdings Ltd
SGX:5CF
|
SG |
|
R
|
RDB Rasayans Ltd
BSE:533608
|
IN |
|
M
|
MPDaesan Inc
KOSDAQ:065150
|
KR |
|
S
|
SHENGFENG DEVELOPMENT Ltd
NASDAQ:SFWL
|
CN |
|
S
|
Seojin System Co Ltd
KOSDAQ:178320
|
KR |
|
B
|
Blitzway Co Ltd
KOSDAQ:369370
|
KR |
|
Asia Vital Components Co Ltd
OTC:AVMPF
|
TW |
|
Highlight Event and Entertainment AG
SIX:HLEE
|
CH |
|
A
|
Amogreentech Co Ltd
KOSDAQ:125210
|
KR |
Bankruptcy Probability
Rhythm Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Rhythm Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
5.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rhythm Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rhythm Pharmaceuticals Inc has total debt of 100.9m USD. This includes both short-term (0 USD) and long-term (100.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
